Answers are grounded in this paper and cite their sources.
effects on the heart. The presence of cardiac hypertrophy in patients receiving long term L-T4 therapy is associated with a marked diastolic dysfunction. The study was performed to investigate the possible effect of suppressive thyroxine treatment (STT) on cardiac functions in athyreotic patients. Methods: Forty-three athyreotic patients (mean age 42 �9 years old, and range from 25 to 56 years old) who received STT to suppress thyrotropin synthesis after surgery and 131 I ablation for differentiated thyroid carcinoma were studied. Scintigraphic evaluation of cardiac functions including left ventricle (LV) ejection fraction (EF), peak filling rate (PFR) and peak ejection rate (PER) was performed during STT [Eltroxin (T4), 4-5 µg/kg/day for 6-12 (mean, 9) months] and 4 weeks after discontinuing treatment. The concomitant blood samples were drawn and were analyzed simultaneously for concentrations of serum TH including T3, T4, TSH and free T4. Results: The thyroid profiles showed that patients were subclinically hyperthyroid with STT and hypothyroid 4 wk after STT withdrawal. The values of PFR and resting
No takes yet. Share an insight, caveat, or question.
Lin et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: